NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 506 / 982

  1. Music-based emotion regulation and healthy and unhealthy music use predict coping strategies in adults with substance use disorder: A cross-sectional study2019 · Crossref
  2. My friends, I’m #SOTALLYTOBER: A longitudinal examination of college students’ drinking, friends’ approval of drinking, and Facebook alcohol-related posts2019 · Crossref
  3. Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial2019 · OpenAlex
  4. Myrcene and terpene regulation of TRPV12019 · OpenAlex
  5. México y el narcoanálisis: una genealogía de las políticas de drogas en los gobiernos Calderón y Peña Nieto2019 · OpenAlex
  6. N-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes2019 · OpenAlex
  7. Nabiximols for the Treatment of Cannabis Dependence2019 · OpenAlex
  8. NAC for cannabis use disorder and depression2019 · Crossref
  9. Nails Analysis for Drugs Used in the Context of Chemsex: A Pilot Study*2019 · OpenAlex
  10. Naloxon – Medizinische Grundlagen und internationale Erfahrungen2019 · OpenAlex
  11. Naloxone Administration by Untrained Community Members2019 · Crossref
  12. Naloxone as a technology of solidarity: history of opioid overdose prevention2019 · OpenAlex
  13. Naloxone interventions in opioid overdoses: a systematic review protocol2019 · OpenAlex
  14. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose2019 · OpenAlex
  15. Naloxone urban legends and the opioid crisis: what is the role of public health?2019 · OpenAlex
  16. NANO-SPONGE NOVEL DRUG DELIVERY SYSTEM AS CARRIER OF ANTI-HYPERTENSIVE DRUG2019 · Crossref
  17. Nasal Septum Defects Detected on Postmortem Computed Tomography2019 · Crossref
  18. National Addiction-specific Institutional Infrastructure - fundamental prerequisite for successful implementation of specialized academic degree study programmes: a case study in historical perspective2019 · OpenAlex
  19. National prevalence, perceptions, and determinants of tobacco consumption in Saudi Arabia2019 · Crossref
  20. Natural and Drug Rewards Engage Distinct Pathways that Converge on Coordinated Hypothalamic and Reward Circuits.2019 · PubMed
  21. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence2019 · OpenAlex
  22. Natural fiber reinforced polymer composites: history, types, advantages, and applications2019 · OpenAlex
  23. Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis2019 · Crossref
  24. Nearly 20 000 e-liquids and 250 unique flavour descriptions: an overview of the Dutch market based on information from manufacturers2019 · OpenAlex
  25. Needle and Syringe Programs in Rural Areas: Addressing the Intravenous Drug Use Epidemic2019 · Crossref
  26. Needle exchange programmes in Visegrad countries: a comparative case study of structural factors in effective service delivery2019 · OpenAlex
  27. Negative marijuana‐related consequences among college students in five countries: measurement invariance of the Brief Marijuana Consequences Questionnaire2019 · OpenAlex
  28. Negotiating Water and Technology—Competing Expectations and Confronting Knowledges in the Case of the Coca Codo Sinclair in Ecuador2019 · Crossref
  29. Neighborhood density of alcohol outlets moderates genetic and environmental influences on alcohol problems2019 · Crossref
  30. Nervous and Immune Systems as Targets for Developmental Effects of Benzodiazepines2019 · Crossref
  31. Network governance and the contemporary opium problem in northern Thailand2019 · Crossref
  32. Neural correlates of the DMT experience as assessed via multivariate EEG2019 · OpenAlex
  33. Neural correlates of the DMT experience assessed with multivariate EEG.2019 · PubMed
  34. Neural correlates of the personality factor openness before and after psilocybin-therapy to depressed patients2019 · OpenAlex
  35. Neurobiological roots of psychopathy2019 · OpenAlex
  36. Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe2019 · OpenAlex
  37. Neurocircuitry of Reward and Addiction: Potential Impact of Dopamine–Glutamate Co-release as Future Target in Substance Use Disorder2019 · Crossref
  38. Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders2019 · OpenAlex
  39. Neurodevelopment and Exposure to Cannabis2019 · Crossref
  40. Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?2019 · Crossref
  41. Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence2019 · OpenAlex
  42. Neuronal network dysfunction in a model for Kleefstra syndrome mediated by enhanced NMDAR signaling2019 · OpenAlex
  43. Neurophysiological and Interpersonal Correlates of Emotional Face Processing in Alcohol Use Disorder2019 · Crossref
  44. Neuroprotective and Antiapoptotic Effects of N-acetylcystein and Crocus sativus Aqueous Extract on Arsenic-induced Neurotoxicity in SH-SY5Y Human Dopaminergic Neuroblastoma Cells2019 · OpenAlex
  45. Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art2019 · OpenAlex
  46. Neuropsychological disorders in juvenile delinquents2019 · OpenAlex
  47. Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders2019 · OpenAlex
  48. Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond2019 · OpenAlex
  49. Neurotensin receptor 1 deletion decreases methamphetamine self‐administration and the associated reduction in dopamine cell firing2019 · Crossref
  50. Neutrophil-mediated antifungal activity against highly virulent Cryptococcus gattii strain R2652019 · Crossref
  51. New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders2019 · OpenAlex
  52. New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory From the American Heart Association2019 · OpenAlex
  53. New Antimalarial and Antimicrobial Tryptamine Derivatives from the Marine Sponge Fascaplysinopsis reticulata2019 · OpenAlex
  54. New Drug Discovery from Medicinal Plants and Phytoconstituents for Depressive Disorders2019 · Crossref
  55. New EST-SSR Markers for Individual Genotyping of Opium Poppy Cultivars (Papaver somniferum L.)2019 · Crossref
  56. New for Who?: Novelty and Continuity in Drug-Related Practices of People Who Use New Psychoactive Substances2019 · Crossref
  57. New Iboga-Type Indole Alkaloids from Tabernaemontana divaricata2019 · Crossref
  58. New psychoactive substances and the risks of consumption in children and adolescents2019 · OpenAlex
  59. New Psychoactive Substances: A Matter of Time2019 · Crossref
  60. New psychoactive substances: An emerging epidemic2019 · OpenAlex
  61. New psychoactive substances: challenges for drug surveillance, control, and public health responses.2019 · PubMed
  62. New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.2019 · OpenAlex
  63. New psychoactive substances: psychiatrist's view2019 · Crossref
  64. New Zealand tobacco retailers’ understandings of and attitudes towards selling Electronic Nicotine Delivery Systems: a qualitative exploration2019 · Crossref
  65. New-generation azaindole-adamantyl-derived synthetic cannabinoids2019 · OpenAlex
  66. Nicotinamide and NAFLD: Is There Nothing New Under the Sun?2019 · Crossref
  67. Nicotinamide as Independent Variable for Intelligence, Fertility, and Health: Origin of Human Creative Explosions?2019 · OpenAlex
  68. Nicotine addiction and substance use disorder treatment: The Philadelphia story2019 · Crossref
  69. Nicotine and Toxicant Exposure Among Concurrent Users (Co-Users) of Tobacco and Cannabis2019 · Crossref
  70. Nicotine Gateway Effects on Adolescent Substance Use2019 · OpenAlex
  71. Nicotine in tobacco product aerosols: ‘It's déjà vu all over again’2019 · Crossref
  72. Nicotine matters in predicting subsequent smoking after e-cigarette experimentation: A longitudinal study among Finnish adolescents2019 · OpenAlex
  73. Nicotine Self-Administration With Tobacco Flavor Additives in Male Rats2019 · Crossref
  74. Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia2019 · Crossref
  75. Nicotinic Mitigation of Neuroinflammation and Oxidative Stress After Chronic Sleep Deprivation2019 · OpenAlex
  76. Nightlife and Drug Use in Tbilisi, Georgia: Results of an Exploratory Qualitative Study2019 · OpenAlex
  77. Nitrous Oxide: What Do We Know about Its Use Disorder Potential? Results of the French Monitoring Centre for Addiction Network Survey and Literature Review2019 · Crossref
  78. NJ governor approves medical cannabis for OUD2019 · Crossref
  79. No end in sight: the international drug control system once again baulks at the prospect of reform2019 · Crossref
  80. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder2019 · Crossref
  81. No Influence of Dopamine System Gene Variations on Acute Effects of MDMA2019 · OpenAlex
  82. No Patient Left Behind: Integrating Addiction Treatment with Buprenorphine into Your Outpatient Palliative Care Practice (TH316)2019 · OpenAlex
  83. No-till System as an Alternative for Soil Conservation Aiming at Sustainability in Tobacco Production2019 · Crossref
  84. Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers2019 · OpenAlex
  85. Nombres populares y clasificación de las drogas de abuso ilícitas en Chile2019 · OpenAlex
  86. Non drug-related and opioid-specific causes of 3262 deaths in Scotland’s methadone-prescription clients, 2009–20152019 · OpenAlex
  87. Non-drug hemp, as a new variety of Cannabis sativa L. convar. non-narcotic Vyrovets2019 · Crossref
  88. Non-Genetic Factors in Schizophrenia2019 · OpenAlex
  89. Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health2019 · OpenAlex
  90. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.2019 · PubMed
  91. Non-pharmacological Considerations in Human Research of Nicotine and Tobacco Effects: A Review2019 · Crossref
  92. Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users2019 · OpenAlex
  93. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities2019 · OpenAlex
  94. Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy2019 · OpenAlex
  95. Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder2019 · Crossref
  96. Nonmedical prescription drug use of analgesics and sedatives/hypnotics in Taiwan: Results from the 2014 National Survey of Substance Use2019 · OpenAlex
  97. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis2019 · OpenAlex
  98. Non‐medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates2019 · Crossref
  99. Norcarfentanil: carfentanil misuse or remifentanil treatment?2019 · OpenAlex
  100. Normalizing Tobacco? The Politics of Trade, Investment, and Tobacco Control2019 · Crossref